Gastric cancer (GC) is one of the
cancers that reveal increased risk of mortality and incidence in atomic bomb survivors. The incidence of
gastric cancer in the Life Span Study cohort of the Radiation Effects Research Foundation (RERF) increased with radiation dose (gender-averaged excess relative risk per Gy = 0.28) and remains high more than 65 years after exposure. To assess a possible role of gene-environment interaction, we examined the dose response for
gastric cancer incidence based on immunosuppression-related
IL-10 genotype, in a cohort study with 200
cancer cases (93 intestinal, 96 diffuse and 11 other types) among 4,690 atomic bomb survivors participating in an immunological substudy. Using a single haplotype block composed of four haplotype-tagging SNPs (comprising the major haplotype allele IL-10-ATTA and the minor haplotype allele IL-10-GGCG, which are categorized by IL-10 polymorphisms at -819A>G and -592T>G, +1177T>C and +1589A>G), multiplicative and additive models for joint effects of radiation and this
IL-10 haplotyping were examined. The
IL-10 minor haplotype allele(s) was a risk factor for intestinal type
gastric cancer but not for diffuse type
gastric cancer. Radiation was not associated with intestinal type
gastric cancer. In diffuse type
gastric cancer, the haplotype-specific excess relative risk (ERR) for radiation was statistically significant only in the major homozygote category of
IL-10 (ERR = 0.46/Gy, P = 0.037), whereas estimated ERR for radiation with the minor
IL-10 homozygotes was close to 0 and nonsignificant. Thus, the minor
IL-10 haplotype might act to reduce the radiation related risk of diffuse-type
gastric cancer. The results suggest that this
IL-10 haplotyping might be involved in development of radiation-associated
gastric cancer of the diffuse type, and that
IL-10 haplotypes may explain individual differences in the radiation-related risk of
gastric cancer.